Autonomic nervous system dysfunction in schizophrenia: impact on cognitive and metabolic health

por Stogios, Nicolette, Gdanski, Alexander, Gerretsen, Philip, Chintoh, Araba F., Graff-Guerrero, Ariel, Rajji, Tarek K., Remington, Gary, Hahn, Margaret K., Agarwal, Sri Mahavir
Publicado 2021

Semaglutide for the treatment of antipsychotic-associated weight gain in patients not responding to metformin – a case series

por Prasad, Femin, De, Riddhita, Korann, Vittal, Chintoh, Araba F., Remington, Gary, Ebdrup, Bjørn H., Siskind, Dan, Knop, Filip Krag, Vilsbøll, Tina, Fink-Jensen, Anders, Hahn, Margaret K., Agarwal, Sri Mahavir
Publicado 2023

Metformin for early comorbid glucose dysregulation and schizophrenia spectrum disorders: a pilot double-blind randomized clinical trial

por Agarwal, Sri Mahavir, Panda, Roshni, Costa-Dookhan, Kenya A., MacKenzie, Nicole E., Treen, Quinn Casuccio, Caravaggio, Fernando, Hashim, Eyesha, Leung, General, Kirpalani, Anish, Matheson, Kelly, Chintoh, Araba F., Kramer, Caroline K., Voineskos, Aristotle N., Graff-Guerrero, Ariel, Remington, Gary J., Hahn, Margaret K.
Publicado 2021